Records 1 - 6
| There is no relationship between SOD2 Val-16Ala polymorphism and breast cancer risk or survival.
Molecular and clinical oncology 2017 Oct 7 (4): 579-590.
Wang Chengdi, Liu Yang, Zhou Jian, Ye Lei, Chen Nan, Zhu Min, Ji Yul
| Systematic meta-analyses of gene-specific genetic association studies in prostate cancer.
Oncotarget 2016 Mar .
Hao Qiang, Wei Dong, Zhang Yaoguang, Chen Xin, Yang Fan, Yang Ze, Zhu Xiaoquan, Wang Jian
| Association between six genetic polymorphisms and colorectal cancer: a meta-analysis.
Genetic testing and molecular biomarkers 2014 Mar 18 (3): 187-95.
Chen Cheng, Wang Lingyan, Liao Qi, Xu Leiting, Huang Yi, Zhang Cheng, Ye Huadan, Xu Xuting, Ye Meng, Duan Shiw
| Association between SOD2 C47T polymorphism and lung cancer susceptibility: a meta-analysis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Aug .
Li N, Huang HQ, Zhang GS
| No association between SOD2 Val16Ala polymorphism and breast cancer susceptibility: a meta-analysis based on 9,710 cases and 11,041 controls.
Breast cancer research and treatment 2010 Jul 122 (2): 509-14.
Ma Xiangyu, Chen Chunhai, Xiong Hongyan, Fan Jin, Li Yafei, Lin Hui, Xu Rufu, Huang Guorong, Xu B
| Superoxide dismutase 2 gene and cancer risk: evidence from an updated meta-analysis.
International journal of clinical and experimental medicine 0 8 (9): 14647-14655.
Kang Sang Wo